---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "IMqci1UtaTH12WeERIMjQbRHSWNH+HJCKwoXabsFyMpVSmZp3poShCB8/Oq6yJIrsuo1RA+fliVrCgOfpGQ6HTG+YfMD1RviEhB7VYG0MVAE0+udJhsiqoM1SdKvfrGw+bW8nhK1i6jW1e19mguC4tvGYoCtyzkE7QUIHYkNfpXz0soRV6bF7iPuNjHPKCgZoCuEV0SJayGic27XYd68H23rizEAftzy1RpFk8pLhhLEmBa9/AphyPXo9ZnBzzNpjy8IORzf3o1KBmt80Mnt+NCVS96LG90+9VYvdgpirlkzvtgApW1w7LSPy2sREp45;p6hzUyagwzZ/FHnDptBnng=="
---

